New YorkRelates to the labeling of mifepristone, misoprostol, and their generic alternatives
What it does
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Feb 3APPROVAL MEMO.1Latest
- Feb 3SIGNED CHAP.7Became Law
- Feb 3DELIVERED TO GOVERNORTo Governor
- Jan 22RETURNED TO SENATE
- Vote recorded Assembly Vote. Result: pass.Lower
- Jan 22PASSED ASSEMBLYPassed 2nd Chamber
- Jan 22ORDERED TO THIRD READING RULES CAL.61
- Jan 22SUBSTITUTED FOR A2145A
- Jan 21REFERRED TO HIGHER EDUCATIONMinor
- Vote recorded Rules Vote - Version: A. Result: pass.Upper
- Vote recorded Floor Vote - Version: A. Result: pass.Upper
- Jan 21DELIVERED TO ASSEMBLY
- Jan 21PASSED SENATEPassed 1st Chamber
- Jan 21ORDERED TO THIRD READING CAL.99
- Jan 21COMMITTEE DISCHARGED AND COMMITTED TO RULESMinor
- Jan 13PRINT NUMBER 36AMajor
- Jan 13AMEND (T) AND RECOMMIT TO HIGHER EDUCATIONMajor
- Jan 8REFERRED TO HIGHER EDUCATIONIntroduced